<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000044482"><TermName>LGD1069</TermName><TermDefinition><DefinitionText>A drug used to treat skin problems caused by cutaneous T-cell lymphoma that have not gotten better after other treatment. It is also being studied in the treatment of other types of cancer. LGD1069 is a type of retinoid. Also called bexarotene and Targretin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>LGD1069</SpanishTermName><SpanishTermDefinition><DefinitionText>Medicamento que se usa para tratar problemas  de la piel  por causa del linfoma cutáneo de células T que no han mejorado después del tratamiento. Asimismo, está en estudio para el tratamiento de otros tipos de cáncer. El LGD1069 es un tipo de retinoide. También se llama bexaroteno y Targretin.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2006-11-29</DateLastModified><RelatedInformation><RelatedDrugSummaryRef href="CDR0000500219">Bexarotene</RelatedDrugSummaryRef></RelatedInformation></GlossaryTerm>
